AIM
XBI icon

Arcadia Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Arcadia Investment Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100
Closed -$8.3K – 378
2022
Q4 		$8.3K Hold
100
– – ﹤0.01% 321
2022
Q3 		$8K Hold
100
– – ﹤0.01% 256
2022
Q2 		$7K Buy
+100
New +$7.51K ﹤0.01% 266

Other funds holding XBI

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Arcadia Investment Management's XBI Position: Q1 2023 in Review

Arcadia Investment Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2023, closing a stake of 100 shares — an estimated $8.3K sold.

Arcadia Investment Management first reported a position in XBI in Q2 2022 and held it in 3 quarters. The position peaked at $8.3K in Q4 2022. 712 funds tracked by Wall St. Rank hold XBI as of Q1 2023.

  • Arcadia Investment Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2023 after selling out during the quarter.
  • Arcadia Investment Management sold 100 State Street SPDR S&P Biotech ETF shares in Q1 2023, an estimated $8.3K.
  • Arcadia Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 3 quarters.
  • Arcadia Investment Management's State Street SPDR S&P Biotech ETF position peaked at $8.3K in Q4 2022.
  • 712 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2023.

Based on Arcadia Investment Management's 13F filing for Q1 2023, filed 5 May 2023.